RITTER PHARMACEUTICALS INC - COM NEW (RTTR)

CUSIP: 767836307

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM NEW
Total 13F shares
968,854
Share change
+968,854
Total reported value
$2,636,000
Price per share
$2.72
Number of holders
10
Value change
+$2,636,000
Number of buys
10

Quarterly Holders Quick Answers

What is CUSIP 767836307?
CUSIP 767836307 identifies RTTR - RITTER PHARMACEUTICALS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of RITTER PHARMACEUTICALS INC - COM NEW (RTTR) as of Q1 2018

As of 31 Mar 2018, RITTER PHARMACEUTICALS INC - COM NEW (RTTR) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 968,854 shares. The largest 10 holders included Alyeska Investment Group, L.P., BAKER BROS. ADVISORS LP, ARMISTICE CAPITAL, LLC, DRW Securities, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., UBS Group AG, ROYAL BANK OF CANADA, WELLS FARGO & COMPANY/MN, and Atlantic Trust Group, LLC. This page lists 10 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.